Clinical Trials Browser

Completed × Uveal Melanoma × aldesleukin × Clear all

NCT00058279 2013-06-20

Monoclonal Antibody Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase 1/2 Completed

Uveal Melanoma, Melanoma